Tennessee Cancer Registry Data
Cancer Data, Data Request, and Publication
The Tennessee Cancer Registry (TCR) strives to present the most complete, accurate, and timely reports of cancer data in the state of Tennessee; however, there is a lag time from the day the information is reported to the state until the information is processed and ready for release. Because this information includes incidence, stage at diagnosis, first course of treatment and vital status, it is a valuable tool in the evaluation of progress toward cancer prevention and control.
Links to Publications
- Cancer in Tennessee 2015-2019
- Cancer Cluster Investigation in New Tazewell, TN
- Cancer in Tennessee 2014-2018
- Cancer in Tennessee 2012-2016
- Cancer in Tennessee 2011-2015
- 2005-2014 Colorectal Cancer in Tennessee Fact Sheet
- Cancer in Tennessee 2010-2014
- 2003-2014 Colorectal Cancer in Tennessee Fact Sheet
- Prostate Cancer Facts & Figures, Tennessee, 2002-2006
- Colorectal Cancer Facts & Figures, Tennessee, 2002-2006
- Lung Cancer Facts & figures, Tennessee, 2001-2005
- Breast Cancer Facts & Figures, Tennessee, 2001-2005
- Tennessee Department of Health Publications
Data Request
Click on the button below to submit a data request:
If the information you want is not included in this section, please contact the TCR:
State of Tennessee Department of Health Policy, Planning and Assessment
Office of Cancer Surveillance
Tennessee Cancer Registry
Andrew Johnson Tower, 2nd Floor
710 James Robertson Parkway
Nashville, Tennessee 37243
Phone 615-741–5548 or 800-547-3558
FAX 615-253-2399
E-Mail: TNCancer.Registry@tn.gov
TCR Research Projects
The TCR supports cancer research by assisting researchers in identifying cancer patients and/or their families for cancer research:
Study of Cause-Specific Mortality and Cancer Incidence in a Combined Cohort of Uranium Enrichment Workers
Principal Investigator: Anderson, Jeri, PhD
Institution: US Department of Energy (DOE)
The impact of Medicaid disenrollment in Tennessee on delays in breast cancer diagnosis and treatment
Principal Investigator: Tarazi, Wafa, MHPA
Institution: Virginia Commonwealth University
Pregnancy in Female Cancer Survivors
Principal Investigator: Howards, Penelope, PhD
Institution: Emory University
Continued Follow-up of PLCO Participants
Principal Investigator: Yu, Kelly, MPH, Ph.D
Institution: National Cancer Institute
Colorectal Cancer (CRC) Stage of Diagnosis and Place: Examining Social Determinants of CRC Stage of Diagnosis
Principal Investigator: Hodges, Jason, MA
Institution: UT Health Science Center
Synchronous Tumors in Tennessee – A Geo-Spatial Analysis
Principal Investigator: Terry, Paul, PhD, MPH
Institution: UT Knoxville Department of Epidemiology
African American Cancer Epidemiology Study (AACES)
Principal Investigator: Terry, Paul, PhD, MPH
Institution: Duke University
Epidemiology of Molecular Risk Factors for Breast Cancer Genetic Predictors for Premalignant Breast Disease
Principal Investigator: Dupont, William, PhD
Institution: Vanderbilt University
The North American Wilms Tumor Study
Principal Investigator: Hung, Rayjean, PhD
Institution: Mt. Sinai Hospital, Toronto, ON, Canada
TN - Osteosarcoma Surveillance Study
Principal Investigator: Gilsenan, Alicia, PhD
Institution: RTI International on behalf of Eli Lilly & Co.
Camp Lejeune Health Survey
Principal Investigator: Ruckart, Perri, MPH
Institution: US Department of Defense
Cohort Cancer Registry Follow-up Study
Principal Investigator: Stampfer, Meir, MD, DrPH
Institution: Harvard University
Southern Community Cohort Study (SCCS) Study of Cancer Occurrences
Principal Investigator: Blot, William, PhD
Institution: International Epidemiology Institute, Rockville, MD
Black Women’s Health Study: A Follow Up Study
Principal Investigator: Rosenberg, Lynn, Sc.D.
Institution: Boston University Medical Center
TN - Forteo Patient Registry Linkage Study
Principal Investigator: Gilsenan, Alicia, PhD
Institution: RTI International on behalf of Eli Lilly & Co.
Nashville Breast Health Study
Principal Investigator: Zheng, Wei, MD, PhD
Institution: Vanderbilt University
Medullary Thyroid Carcinoma Surveillance Study: a Case-Series Registry
Principal Investigator: Smallridge, Robert, MD
Institution: United Biosource Corporation on behalf of Novo Nordisk, Inc.
Cancer Epidemiology in Adventists
Principal Investigator: Fraser, Gary, MD, PhD
Institution: Loma Linda University
Analysis of Cancer Risks in Populations Near Nuclear Facilities
Principal Investigator: Rania Kosti, PhD
Institution: National Academy of Sciences
Confidentiality Statement
All information obtained on patients shall be considered extremely classified. Absolutely no personal or identifying information, such as name or social security number, can be released to researchers unless Institutional Review Board Approval is obtained. All information shall be used solely for statistical, scientific and medical research purposes and shall be held strictly confidential by the TCR.